The Hsp90 chaperone complex - A potential target for cancer therapy?

被引:0
|
作者
Darimont, BD [1 ]
机构
[1] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:195 / 198
页数:4
相关论文
共 50 条
  • [31] Hsp90 as an anti-cancer target
    Neckers, L
    Mimnaugh, E
    Schulte, TW
    DRUG RESISTANCE UPDATES, 1999, 2 (03) : 165 - 172
  • [32] Hsp90 and Cdc37 - a chaperone cancer conspiracy
    Pearl, LH
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) : 55 - 61
  • [33] Altered states: selectively drugging the Hsp90 cancer chaperone
    Workman, P
    TRENDS IN MOLECULAR MEDICINE, 2004, 10 (02) : 47 - 51
  • [34] The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor
    Kazlauskas, A
    Sundström, S
    Poellinger, L
    Pongratz, I
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (07) : 2594 - 2607
  • [35] A novel HSP90 chaperone complex regulates intracellular vesicle transport
    Lotz, Gregor P.
    Brychzy, Alexander
    Heinz, Stefan
    Obermann, Wolfgang M. J.
    JOURNAL OF CELL SCIENCE, 2008, 121 (05) : 717 - 723
  • [36] Rab-αGDI activity is regulated by a Hsp90 chaperone complex
    Sakisaka, T
    Meerlo, T
    Matteson, J
    Plutner, H
    Balch, WE
    EMBO JOURNAL, 2002, 21 (22): : 6125 - 6135
  • [37] Hsp90 as a Potential Therapeutic Target in Retinal Disease
    Aguila, Monica
    Cheetham, Michael E.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2016, 854 : 161 - 167
  • [38] Molecular chaperone HSP90α isoform 1 forms telomerase complex
    Zhdanov, Dmitry
    Kovalenko, Natalia
    Orlova, Elena
    FASEB JOURNAL, 2010, 24
  • [39] Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy
    Abdullah, Omeima
    Omran, Ziad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [40] Targeting the dynamic HSP90 complex in cancer
    Trepel, Jane
    Mollapour, Mehdi
    Giaccone, Giuseppe
    Neckers, Len
    NATURE REVIEWS CANCER, 2010, 10 (08) : 537 - 549